Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-05-08 00:00:00 ET · period of report 2024-05-06 · accession 0001415889-24-012652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-08 | 2024-05-06 | ELVN | Patel Anish | COO | M - OptEx | $2.48 | +4,875 | 4,875 | New | +$12.1K |
| D | 2024-05-08 | 2024-05-06 | ELVN | Patel Anish | COO | S - Sale+OE | $22.72 | -4,875 | 0 | -100% | -$110.8K |
| D | 2024-05-08 | 2024-05-06 | ELVN | Patel Anish | COO | M - OptEx | $0.00 | -4,875 | 55.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-06 | M | A | 4,875 | $2.48 | 4,875 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-06 | S | D | 4,875 | $22.72 | 0 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $22.295 to $22.9429. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-05-06 | M | D | 4,875 | $0.00 | 55,842 | D | $2.48 · — to 2031-03-25 | 4,875 Common Stock | (F4) The option, originally for 75,620 shares, vests in 48 equal monthly installments beginning on August 14, 2021. |